Investing In Organon & Co. (NYSE: OGN): Why Should You?

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

The company is listed on the NYSE and operates within the Drug Manufacturers – General industry segment. The current market capitalization of Organon & Co. is $4.53B. A total of 2.98 million shares were traded on the day, compared to an average of 2.43M shares.

In the most recent transaction, Weaver Kirke bought 2,720 shares of OGN for 18.36 per share on Feb 22 ’24. After the transaction, the Gen. Counsel & Corp. Secy. now owns 15,181 company shares.

Dividend

The dividend paying company demonstrates a positive outlook for investors and helps them generate immediate cash. Organon & Co. pays an annual dividend of $1.12, resulting in a dividend yield of 6.32%, and it has a price to earnings (P/E) ratio of 4.44. OGN’s most recent ex-dividend date was 2/23/2024 when it declared a $0.28 quarterly dividend that was paid in cash on 3/14/2024. Previously, the company paid the dividend on 12/14/2023 with an ex-dividend date of 11/10/2023. The OGN stock dividend was $0.28 per share in cash.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, OGN has a high of $24.79 and a low of $10.84.

As of this writing, OGN has an earnings estimate of $ON Semiconductor Corporation per share for the current quarter. EPS was calculated based on a consensus of Ocugen, Inc. estimates, with a high estimate of $Origin Materials, Inc. per share and a lower estimate of $Organon & Co..

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. OGN’s latest balance sheet shows that the firm has $737.00M in Cash & Short Term Investments as of fiscal 2021. There were $9.13B in debt and $2.60B in liabilities at the time. Its Book Value Per Share was -$0.27, while its Total Shareholder’s Equity was -$1.51B.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for OGN is Buy with a score of 3.43.

Most Popular

Related Posts